Novoheart Holdings IncTSXV: NVH

Novoheart Holdings Inc. Opens the Market

· Issued by Novoheart Holdings Inc via CNW

TORONTO, Oct. 12, 2017 /CNW/ - Professor Ronald Li, CEO & Scientific Co-Founder, Novoheart Holdings Inc., joined Rob Peterman, Vice-President, Global Business Development, TMX Group, to open the market. Novoheart is a global stem cell biotechnology company dedicated to human heart engineering with offices in Vancouver, British Columbia, the United States and Hong Kong. Novoheart Holdings Inc. commenced trading on TSX Venture Exchange on October 3, 2017.

Novoheart Holdings Inc. Opens the Market (CNW Group/TMX Group Limited)

SOURCE TMX Group Limited

View original content with multimedia: http://www.newswire.ca/en/releases/archive/October2017/12/c2976.html

Copyright CNW Group 2017

View original source (CNW)Novoheart Holdings Inc on 6ix

Later from Novoheart

All Novoheart news releases